Researchers from the hereditary ataxias and paraplegias CSUR os the University Hospital Marques de Valdecilla and IDIVAL´s neurodegenerative diseases group led by Dr. Jon Infante, participate in a Eu...
Read moreThe BioClotAD project, coordinated by Centro Nacional de Investigaciones Cardiovasculares (CNIC) scientist Dr Marta Cortés Canteli, who is supported by Spain's Miguel Servet Program, has been sele...
Read moreMinoryx Therapeutics, a Phase 3 clinical stage biotech company focused on the development of differentiating treatment options in orphan central nervous system (CNS) disorders, today announces that th...
Read moreAn article published in the Journal of Medicinal Chemistry shows a new family of molecules with high affinity to join imidazoline receptors, which are altered in the brain of those patients with ne...
Read moreA study led by the researchers of our centre shows that microglia is a sensor of newborn neuron death and maintains the equilibrium between life and death
Read moreResearchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer’s, according to a study published in Jour...
Read moreIDIBELL and the Temporing Group Company, headquartered in Barcelona, have reached a sponsorship agreement to boost funding for research on amyotrophic lateral sclerosis (ALS). Temporing is one of the ...
Read moreLiquid droplets of molecules inside cells – similar to the blobs that form when oil and vinegar are mixed – could be behind neurodegenerative conditions such as Parkinson’s and motor neurone dis...
Read more